Skip to content
Home
Team
Therapies
Overview/Pipeline
IC/BPS
Alenura™
Investor
News
Contact Us
Investor Login

We Are Improving Patient’s Lives by Developing Treatments for Areas of High Unmet Medical Need in Urology

Learn More
Vaneltix specializes in urology and women’s health care, focused on providing immediate relief for patients suffering from Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS), a disease of the lower urinary tract that predominantly affects women.

Latest News

Vaneltix planning to enroll subjects in new round of clinical trials

February 21, 2023

Vaneltix enters joint development agreement with Hyloris Pharmaceuticals

December 21, 2021

Subscribe for Updates

By subscribing, you agree to receive emails from Origin. You may choose to unsubscribe at any time

Overview

We Specialize in Urology and Women’s Health Care

Pain, urgency, frequency. Every day, urologic disorders continue to affect the lives of people all around us.

Vaneltix is focused on providing immediate relief for patients suffering from Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS), a disease of the lower urinary tract that predominantly affects women.

For many, the path to a brighter more comfortable future, is Vaneltix.

What we offer

Vaneltix Pipeline Represents Promising Medicines for Millions of People Suffering from Urological Disorders

Vaneltix flagship product Alenura™ is combination product of heparin and alkalinized lidocaine for the immediate relief of acute pelvic pain associated with IC/BPS. Additional products in development include an enhanced formulation of the IC/BPS drug Elmiron and a regenerative therapy of the bladder wall lining for urologic orphan disease indications.

Learn More

WHO WE ARE

Led by a Seasoned Team of Dedicated Pharmaceutical Professionals and Renowned Urologists

Our team members rank among top US top experts in bladder dysfunction and urological pain. Our Management and Board have significant experience in the FDA approval of new medicines, the development and marketing of urology products and in the creation of valuable new dosage forms.

Learn More

Learn More About Vaneltix’s Focus and Treatments

Learn More
Vaneltix Pharma, Inc.
305 E High Street, Ste. 7,
Bound Brook, NJ 08805
United States
  • Tel:

    (732) 369-5911
  • Fax:

    (732) 356-1125
  • Email:

    Info@vaneltix.com
Team
Therapies
Investor
News
Contact Us
2021 © Vaneltix. All rights reserved.
Privacy Policy
Privacy Policy
This website is created by Blink.